FDA Approves Rejoyn: The First Prescription App-Based Treatment for Depression
The FDA has authorized Rejoyn — the first prescription digital therapeutic app specifically designed for major depressive disorder. Here’s everythingContinue Reading
The FDA has authorized Rejoyn — the first prescription digital therapeutic app specifically designed for major depressive disorder. Here’s everythingContinue Reading
In recent years, the rate of anxiety and depression among teenagers has significantly increased, raising concerns among parents, educators, andContinue Reading
Chronic respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis not only affect lung function but alsoContinue Reading
Diabetes and depression have a significant interrelationship, with each condition potentially exacerbating the other. Here’s a deeper look at theirContinue Reading
Chronic pain and depression are deeply interconnected, creating a cycle that can significantly impact an individual’s quality of life. PeopleContinue Reading
The connection between inflammation and depression is a groundbreaking discovery in mental health research. Traditionally, depression has been primarily viewedContinue Reading
Depression is more than just a feeling of sadness or a temporary emotional downturn. It is a complex mental healthContinue Reading

